On Oct 28, 2025, CHE reported earnings of 5.27 USD per share (EPS) for Q3 25, missing the estimate of 5.42 USD, resulting in a -2.88% surprise. Revenue reached 624.90 million, compared to an expected 632.29 million, with a -1.17% difference. The market reacted with a +6.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 7.13 USD, with revenue projected to reach 665.68 million USD, implying an increase of 35.29% EPS, and increase of 6.53% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
DaVita Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$3.18
Actual
$3.39
Surprise
+6.37%
Encompass Health Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.31
Actual
$1.46
Surprise
+11.35%
FAQ
What were Chemed Corporation's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Chemed Corporation reported EPS of $5.27, missing estimates by -2.88%, and revenue of $624.90M, -1.17% below expectations.
How did the market react to Chemed Corporation's Q3 2025 earnings?
The stock price moved up 6.06%, changed from $438.94 before the earnings release to $465.54 the day after.
When is Chemed Corporation expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Chemed Corporation's next earnings report?
Based on 5
analysts, Chemed Corporation is expected to report EPS of $7.13 and revenue of $665.68M for Q4 2025.